Publications - Alzheimer's Disease

Back to Areas of Research list.  

Advanced glycation and lipid modifications of Rosenthal fibers in Alexander disease. Castellani, R., Perry, G., Harris, P.L.R., Monner, V.M., Cohen, M.L., Salonon, R.G., Sayre, L.M. and Smith, M.A. J. Neuropathol. Exp. Neurol. 56:595, 1997. [abstract] 

Advanced glycation modification of Rosenthal fibers in patients with Alexander's disease. Castellani, R.J., Perry, G. Harris, PlL., Monnier, V.M., Cohen, M.L. and Smith, M.A. Neurosci. Lett. 231:79-82, 1997. [paper] 

Advanced lipid peroxidation end-products in Alexander's disease. Castellani, R.J., Perry, G., Harris, P.L.R., Cohen, M.L., Sayre, L.M., Salomon, R.G. and Smith, M.A. Brain Res. 787:15-18, 1998. [paper] 

Alexander disease: Alzheimer disease of the developing brain? Castellani, R.J., Perry, G., Brenner, D.S. and Smith, M.A. Alzheimer Dis. Assc. Disord. 13:232-235, 1999. [paper] 

GFAP mutations in infantile, juvenile, and adult Alexander disease. Li, R., Johnson, A., Salomons, G., Goldman, J., Naidu, S., Quinlan, R., Cree, B., Ruyle, S., Banwell, B., D'Hooghe, M., Siebert, J., Rolf, C., Cox, H., Reddy, A., Gonzÿlez, L., Collins, A., Weller, R., Messing, A., van der Knaap, M. and Brenner, M. [paper] 

Gene expression analysis in mice with elevated glial fibrillary acidic protein and Rosenthal fibers reveals a stress response followed by glial activation and neuronal dysfunction. Hagemann, T., Gaeta, S., Smith, M., Johnson, D., Johnson, A. and Messing, A. Human Molecular Genetics, 14: 2443-2458, 2005. [paper] 

Glial fibrillary acidic protein mutations in infantile, juvenile, and adultfForms of Alexander Disease. Li, R., Johnson, A., Salomons, G., Goldman, J., Naidu, S., Quinlan, R., Cree, B., Ruyle, S., Banwell, B., D'Hooghe, M., Siebert, J., Rolf, C., Cox, H., Reddy, A., Gutierrez-Solana, L., Collins, A., Weller, R., Messing, A., van der Knaap, M., Brenner, M. Ann. Neurol. 57: 310-326, 2005. [paper] 

High molecular weight, GFAP aggregates in Alexander disease. Johnson, A.B. and F.-C. Chiu J. Neuropath. Exp. Neurol. 57:483, 1998. [abstract] 

High-molecular-weight GFAP-positive aggregates in Alexander's disease. Johnson, A.B. and Chiu, F.-C. J. Mol. Neurosci. 13:230-231, 1999. [paper] 

Mutations in GFAP associated with Alexander disease. Messing, A., Johnson, A.B., Boesplug-Tanuguy, O., Rodriguez, D., Goldman, J.E. and Brenner, M. J. Neuropath. Exp. Neurol. 59:455, 2000. [abstract] 

Mutations in GFAP associated with infantile juvenile and adult forms of Alexander disease. Brenner, M., Johnson, A.B., Boesppflug-Tanguy, O., Rodriguez, D., Goldman, J.E. and Messing, A. J. Neurochem. 74:S4, 2000. [abstract] 

Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease. Brenner, M., Johnson, A., Boespflug-Tanguy, O., Rodriguez, D., Goldman, J. and Messing, A. Nature Genetics 27: 117-120, 2001. [paper] 

Oxidative protein modifications in Rosenthal fibers: implications for Alexander's disease pathogenesis. Castellani, R.J., Perry, G., Harris, and Smith, M.A. Free Radicals in Brain Pathophysiology, Chapter 18: 383-392, 2000. [paper] 

Propensity for paternal inheritance of de novo mutations in Alexander disease. Li, R., Johnson, A., Salomons, G., van der Knaap, M., Rodriguez, D., Boespflug-Tanguy, O., Gorospe, J., Goldman, J., Messing, A. and Brenner, M. Hum. Genet. 119:137-144, 2006. [paper] 

Recent studies on Alexander disease. Johnson, A.B. and Chiu, F.-C. J. Mol. Neurosci. 12:202, 1999. [paper]